STOCK TITAN

American Vanguard Corp - AVD STOCK NEWS

Welcome to our dedicated page for American Vanguard news (Ticker: AVD), a resource for investors and traders seeking the latest updates and insights on American Vanguard stock.

American Vanguard Corporation (AVD) is a leading US-based company that specializes in the development, manufacturing, and marketing of specialty chemicals. Founded in 1969, American Vanguard operates through its subsidiaries to serve agricultural, commercial, and consumer markets both domestically and internationally.

The company produces a wide range of chemicals including insecticides, fungicides, herbicides, molluscicides, growth regulators, and soil fumigants. These products are available in various formulations such as liquid, powder, and granular forms, catering to crops, turf, ornamental plants, as well as human and animal health protection.

American Vanguard's product line includes well-known formulations like PCNB, chlorothalonil, and propiconazole, marketed under the FFII and FFIII names. The company ensures these products reach their target markets through a robust distribution network. This network features national distribution companies, buying groups, co-operatives, and direct sales channels, including sales offices, sales agents, and wholly owned distributors.

In addition to chemical products, American Vanguard also markets and distributes end-use chemical and biological products for crop applications and the greenhouse and nursery production markets. The company's commitment to quality and innovation has solidified its reputation in the industry, enabling it to form strategic partnerships and expand its market presence.

Recent Achievements and Current Projects: American Vanguard has recently focused on enhancing its product portfolio through research and development. The company invests in innovative solutions to meet evolving market demands and regulatory requirements. It continues to work on projects aimed at improving agricultural productivity and sustainability.

Financial Condition: American Vanguard’s financial performance reflects its strong market position and diversified product offerings. The company consistently reports revenue growth and profitability, highlighting its effective management and strategic direction.

American Vanguard Corporation remains a significant player in the specialty chemicals industry, contributing to advancements in agriculture, commercial applications, and consumer health protection. Its comprehensive product range and strategic market approach make it a valuable entity for stakeholders and investors.

Rhea-AI Summary

American Vanguard Corporation (NYSE: AVD) announced that Cruiser Capital is seeking co-investors for an undisclosed investment strategy related to AVD. The Company urges stockholders to vote 'FOR ALL' of its nine director nominees on the WHITE proxy card during the upcoming Annual Meeting on June 1, 2022. The Board emphasizes the importance of transparency regarding Cruiser's proposal and recommends disregarding any proxy cards from Cruiser Capital. A definitive proxy statement has been filed with the SEC, and shareholders are advised to review it for important information.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
7.87%
Tags
none
-
Rhea-AI Summary

American Vanguard Corporation (NYSE: AVD) has sent a letter to stockholders ahead of its Annual Meeting on June 1, 2022. The Board urges stockholders to vote 'FOR ALL' nine nominated directors using the 'WHITE' proxy card and to ignore any proxy from Cruiser Capital. Highlights include a 37% year-to-date stock appreciation, outpacing the Russell 2000's 19% decline. The Board is committed to long-term value creation and plans to appoint at least two new directors by 2023. The letter stresses maintaining the current strategy to drive future growth.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
3.41%
Tags
none
-
Rhea-AI Summary

Cruiser Capital Master Fund LP, a significant shareholder in American Vanguard (NYSE: AVD), criticized the company's recent proxy statement for lacking transparency regarding corporate governance improvements. Cruiser claims AVD has failed to prioritize the separation of the Chairman and CEO roles, which they argue is essential for shareholder interests. They highlighted that AVD's total shareholder return has underperformed relative to peers over the years and raised concerns about declining EBITDA margins despite increased sales. Cruiser urges shareholders to vote for their nominees using the BLUE proxy card.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.75%
Tags
none
Rhea-AI Summary

American Vanguard (NYSE: AVD) announced the ongoing process to refresh its Board of Directors, initiated in 2018, by adding two independent directors by the end of 2023. This move is aimed at enhancing the board's skillsets and diversity to align with the company’s strategic growth objectives. The board is actively seeking stockholder input and has received positive feedback during discussions. While the company continues to navigate challenges, including the impact of the COVID-19 pandemic on its operations, it emphasizes the importance of effective governance in driving value creation for shareholders.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.75%
Tags
none
-
Rhea-AI Summary

Cruiser Capital, a significant shareholder of American Vanguard (AVD), owning 2.5% of shares, criticized the company's Board for underperformance and governance issues. They claim AVD's stock price has declined over the past decade compared to peers. Cruiser urges shareholders to support their director nominees to implement necessary changes. AVD's recent financial disclosures raised concerns over transparency, including a reported $222 million in sales and a 15% EBITDA margin, leading to questions about the accuracy and context of these figures. They stress the need for independent oversight to enhance shareholder value.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-3.29%
Tags
none
-
Rhea-AI Summary

American Vanguard Corporation (NYSE: AVD) has issued a letter to stockholders ahead of its Annual Meeting scheduled for June 1, 2022. The letter emphasizes the qualifications of the Company’s nine director nominees and urges stockholders to vote for them on the WHITE proxy card. The Board highlights its past performance, including outperformance of the Russell 2000 and consistent dividend payments, while countering claims made by Cruiser Capital regarding their nominees. American Vanguard asserts its nominees possess superior experience and capability to maintain the Company’s growth trajectory.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.79%
Tags
management
Rhea-AI Summary

Cruiser Capital, a significant shareholder of American Vanguard Corporation (NYSE:AVD), holding 2.5% of shares, has called for major changes in the company's board. In a recent presentation, Cruiser highlighted a decade of underperformance and the need for improved corporate governance. They are urging stockholders to vote for Cruiser's three nominees at the upcoming Annual Meeting on June 1, 2022, to enhance operational efficiency and long-term shareholder value. Cruiser emphasizes that current board members exhibit an entrenched mindset detrimental to stakeholders.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
5.37%
Tags
none
-
Rhea-AI Summary

American Vanguard Corporation (NYSE: AVD) reported strong Q1 2022 results, exceeding revenue and EBITDA targets, driven by strategic actions and technological innovations. Net sales increased from $116.2 million to $149.4 million, while net income rose from $3.1 million to $9.9 million, marking a 219.4% growth. The company anticipates mid-double-digit growth for the year. The board recommends stockholders vote for its nine experienced director nominees against Cruiser Capital, whose candidates lack a clear plan. The annual meeting is set for June 1, 2022.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.58%
Tags
none
-
Rhea-AI Summary

American Vanguard Corporation (NYSE: AVD) reported a strong start to fiscal 2022, with net sales increasing by 29% to $149.4 million and net income surging 224% to $9.9 million for Q1 2022 compared to Q1 2021. Earnings per diluted share rose to $0.33. The EBITDA also improved significantly to $22.9 million. The company achieved a 41% gross profit margin while reducing operating expenses to 31% of sales. Growth was driven by increased demand for crop protection solutions and successful international expansions.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.47%
Tags
none
Rhea-AI Summary

American Vanguard Corporation (NYSE: AVD) will report its financial results for Q1 ended March 31, 2022, on May 4, 2022, after market close. A conference call will follow at 4:30 PM ET, led by CEO Eric Wintemute, COO Bob Trogele, and CFO David T. Johnson. Investors can join by calling 862-298-0702 or via live webcast on the company’s website. American Vanguard specializes in agricultural products and is included in the Russell 2000 and S&P SmallCap 600 Indexes.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.84%
Tags

FAQ

What is the current stock price of American Vanguard (AVD)?

The current stock price of American Vanguard (AVD) is $5.28 as of February 21, 2025.

What is the market cap of American Vanguard (AVD)?

The market cap of American Vanguard (AVD) is approximately 155.7M.

What does American Vanguard Corporation do?

American Vanguard develops, manufactures, and markets specialty chemicals for agricultural, commercial, and consumer uses.

What types of products does American Vanguard offer?

The company offers insecticides, fungicides, herbicides, molluscicides, growth regulators, and soil fumigants in liquid, powder, and granular forms.

In which markets does American Vanguard operate?

American Vanguard serves markets in the United States and internationally, including agriculture, commercial, and consumer sectors.

How does American Vanguard distribute its products?

The company distributes its products through national distribution companies, co-operatives, sales offices, sales agents, and wholly owned distributors.

What are some of American Vanguard's well-known formulations?

Some of the well-known formulations include PCNB, chlorothalonil, and propiconazole, marketed under the FFII and FFIII names.

Does American Vanguard invest in research and development?

Yes, the company invests in innovative solutions for agricultural productivity and sustainability through research and development.

What is American Vanguard’s financial performance like?

The company consistently reports revenue growth and profitability, reflecting its strong market position and effective management.

When was American Vanguard Corporation founded?

American Vanguard Corporation was founded in 1969.

What is the significance of American Vanguard in the industry?

American Vanguard is a significant player in the specialty chemicals industry, contributing to advancements in agriculture and consumer health protection.

What are American Vanguard's recent achievements?

The company has enhanced its product portfolio and continues to focus on projects aimed at improving agricultural productivity and sustainability.
American Vanguard Corp

NYSE:AVD

AVD Rankings

AVD Stock Data

155.74M
25.72M
9.32%
77.26%
3.92%
Agricultural Inputs
Agricultural Chemicals
Link
United States
NEWPORT BEACH